• 1. Novel phosphorescent iridium(iii) emitters for both vacuum-deposition and inkjet-printing of OLEDs with exceptionally high efficiency
  Yong-Xu Hu,Tong Lin,Xin Xia,Wan-Ying Mu,Yu-Ling Sun,Wen-Ze He,Chang-Ting Wei,Dong-Yu Zhang,Xiao Li,Zheng Cui J. Mater. Chem. C 2019 7 4178

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridine carboxaldehydes

Professional Introduction to 2,6-Difluoronicotinaldehyde (CAS No. 155601-65-3)

2,6-Difluoronicotinaldehyde, with the chemical formula C₆H₃Cl₂O, is a fluorinated derivative of nicotinaldehyde, a compound of significant interest in the field of pharmaceutical chemistry and medicinal biology. This compound has garnered attention due to its unique structural properties and potential applications in the development of novel therapeutic agents. The presence of two fluorine atoms at the 2- and 6-positions of the pyridine ring introduces electronic and steric effects that can modulate the biological activity of the molecule, making it a valuable scaffold for drug discovery.

The synthesis of 2,6-Difluoronicotinaldehyde typically involves fluorination reactions on nicotinaldehyde or its precursors. Advanced fluorination techniques, such as electrophilic aromatic substitution or metal-catalyzed cross-coupling reactions, are often employed to achieve high selectivity and yield. The compound's stability under various reaction conditions makes it a versatile intermediate in organic synthesis, particularly in the construction of more complex heterocyclic structures.

In recent years, 2,6-Difluoronicotinaldehyde has been explored for its pharmacological potential. Its fluorinated pyridine core is a common motif in bioactive molecules, contributing to interactions with biological targets such as enzymes and receptors. Preliminary studies have indicated that derivatives of this compound may exhibit properties relevant to antiviral, antibacterial, and anti-inflammatory applications. The fluorine atoms can enhance metabolic stability and binding affinity, which are critical factors in drug design.

The compound's relevance extends to the field of medicinal chemistry, where it serves as a building block for the synthesis of more sophisticated molecules. Researchers have leveraged its reactivity to develop libraries of analogs for high-throughput screening (HTS) campaigns. These efforts have led to the identification of lead compounds with promising biological activity. For instance, modifications at the aldehyde group have been investigated for their potential to form Schiff bases or other covalent linkages with biological targets.

The role of fluorine in medicinal chemistry is well-documented, and 2,6-Difluoronicotinaldehyde exemplifies how strategic incorporation of fluorine can enhance drug-like properties. Fluorinated compounds often exhibit improved pharmacokinetic profiles due to altered lipophilicity and metabolic resistance. This characteristic makes them attractive candidates for further development into clinical candidates. The aldehyde functionality further adds utility by allowing conjugation to biomolecules or participation in condensation reactions.

In academic research, 2,6-Difluoronicotinaldehyde has been used in studies exploring the effects of fluorination on molecular recognition processes. Computational chemistry approaches have been employed to model interactions between this compound and biological targets, providing insights into its mechanism of action. These studies highlight the importance of structural optimization in achieving desired pharmacological effects.

The compound's synthetic versatility has also been exploited in material science applications beyond pharmaceuticals. For example, it has been utilized in the preparation of functional materials such as liquid crystals or organic semiconductors. The electron-withdrawing nature of the fluorine atoms influences electronic properties, making it a valuable component in advanced materials design.

The future prospects for 2,6-Difluoronicotinaldehyde are promising, with ongoing research focusing on expanding its utility in drug discovery and material science. Collaborative efforts between academia and industry are expected to accelerate the development of novel derivatives with enhanced therapeutic potential. As computational methods improve, virtual screening approaches will likely play a greater role in identifying promising candidates for experimental validation.

In conclusion, 2,6-Difluoronicotinaldehyde (CAS No. 155601-65-3) is a multifaceted compound with significant applications in pharmaceutical chemistry and beyond. Its unique structural features and reactivity make it a valuable intermediate for synthesizing bioactive molecules. Continued research will likely uncover new applications and refine synthetic methodologies, solidifying its role as an important chemical entity in modern science.

• 393-55-5(2-Fluoronicotinic acid)
• 79574-70-2(3-Acetyl-2-fluoropyridine)
• 36404-90-7(2-fluoropyridine-3-carbaldehyde)
• 884495-04-9(6-fluoro-5-methylpyridine-3-carbaldehyde)
• 677728-92-6(6-fluoropyridine-3-carbaldehyde)
• 1227602-25-6(2,5-Difluoronicotinaldehyde)
• 1160993-95-2(2-Fluoro-5-methylpyridine-3-carbaldehyde)
• 1227564-60-4(2,4-Difluoro-pyridine-3-carbaldehyde)
• 609771-39-3(2-Fluoro-4-methylnicotinaldehyde)
• 920036-27-7(1-(2,6-Difluoropyridin-3-yl)ethanone)